| Analysis | Metabolite Name | Measured Value | Units | GROUP_ID |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 0.3556 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 0.4793 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 0.5161 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 0.5812 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 0.7416 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 0.8813 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 1.1187 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 1.1751 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 1.2795 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 1.4174 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 1.6888 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 2.2611 | Relative Abundance | CON |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|